Skip to main content
BOSTON SCIENTIFIC CORP logo

BOSTON SCIENTIFIC CORP — Investor Relations & Filings

Ticker · BSX ISIN · US1011371077 LEI · Y6ZDD9FP4P8JSSJMW954 US Manufacturing
Open in API
Filings indexed 3,157 across all filing types
Latest filing 2023-02-06 Director's Dealing
Country US United States of America
Listing US BSX

About BOSTON SCIENTIFIC CORP

https://www.bostonscientific.com/en-US/…

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and commercializes a broad range of high-performance medical devices. The company's products are used in various minimally invasive, interventional medical specialties, including cardiology, endoscopy, neuromodulation, urology, and pelvic health. Focused on transforming lives through innovative solutions, Boston Scientific is dedicated to improving the health of patients worldwide by addressing complex healthcare challenges and enhancing clinical outcomes.

Recent filings

Filing Released Lang Actions
Director's Dealing 2023
Director's Dealing
2023-02-06 English
SEC SCHEDULE 13G
Major Shareholding Notification
2023-02-06 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce significant events. The text specifically mentions that Boston Scientific Corporation issued a press release announcing financial results for the fourth quarter and full year ended December 31, 2022, and that the press release is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. The length of the document is 3854 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, if a document is short and states that a report or release is furnished or attached, it should be classified as a Regulatory Filing (RNS) rather than an Earnings Release (ER) or Annual Report (10-K). Therefore, this document is best classified as a Regulatory Filing (RNS).
2023-02-01 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce significant events. The key content is about the departure of a director, Donna A. James, who will not stand for re-election at the upcoming Annual Meeting. This is a clear announcement of a change in the company's board of directors. The document does not contain financial statements or detailed financial data, nor is it an earnings release or annual report. It specifically fits the category of Board/Management Information (MANG) as it announces changes in the company's board of directors.
2023-01-31 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-01-24 English
Director's Dealing 2023
Director's Dealing
2023-01-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.